Imeik Technology Development Co Cash Flow Conversion Efficiency
Imeik Technology Development Co cash flow conversion efficiency. Based on the latest financial reports, Imeik Technology Development Co (300896) has a cash flow conversion efficiency ratio of 0.032x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥257.61 Million ≈ $37.70 Million USD) by net assets (CN¥8.16 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Imeik Technology Development Co (2014–2025)
Cash flow conversion efficiency of Imeik Technology Development Co from 2014 to 2025. This chart illustrates how Imeik Technology Development Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300896 live share price for real-time trading data and today's change.
Imeik Technology Development Co Cash Flow Conversion Ratio Explained
Imeik Technology Development Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Imeik Technology Development Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imeik Technology Development Co ranked by their cash flow conversion efficiency. Also see market cap of Imeik Technology Development Co for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kaori Heat Treatment Co Ltd
TW:8996
|
0.163x |
|
Aris Mining Corporation
NYSE MKT:ARMN
|
0.070x |
|
Comstock Resources Inc
NYSE:CRK
|
0.054x |
|
Lien Viet Post Joint Stock Commercial Bank
VN:LPB
|
0.284x |
|
Grinm Advanced Materials Co Ltd
SHG:600206
|
-0.092x |
|
MAZDA MOTOR UNSP.ADR/2
F:MZA0
|
N/A |
|
Neway Valve suzhou Co Ltd
SHG:603699
|
0.151x |
|
Cathay Biotech Inc
SHG:688065
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Imeik Technology Development Co (2014–2025)
The table below shows the annual cash flow conversion efficiency of Imeik Technology Development Co from 2014 to 2025. Review cash generation quality of Imeik Technology Development Co to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.16 Billion ≈ $1.19 Billion |
CN¥1.39 Billion ≈ $202.93 Million |
0.170x | -29.93% |
| 2024-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥1.93 Billion ≈ $282.01 Million |
0.242x | -19.55% |
| 2023-12-31 | CN¥6.49 Billion ≈ $948.97 Million |
CN¥1.95 Billion ≈ $285.94 Million |
0.301x | +50.06% |
| 2022-12-31 | CN¥5.95 Billion ≈ $870.05 Million |
CN¥1.19 Billion ≈ $174.71 Million |
0.201x | +7.13% |
| 2021-12-31 | CN¥5.03 Billion ≈ $736.01 Million |
CN¥942.78 Million ≈ $137.96 Million |
0.187x | +99.53% |
| 2020-12-31 | CN¥4.53 Billion ≈ $663.06 Million |
CN¥425.68 Million ≈ $62.29 Million |
0.094x | -79.90% |
| 2019-12-31 | CN¥662.70 Million ≈ $96.97 Million |
CN¥309.72 Million ≈ $45.32 Million |
0.467x | +39.60% |
| 2018-12-31 | CN¥404.74 Million ≈ $59.23 Million |
CN¥135.50 Million ≈ $19.83 Million |
0.335x | +30.60% |
| 2017-12-31 | CN¥328.31 Million ≈ $48.04 Million |
CN¥84.16 Million ≈ $12.32 Million |
0.256x | +23.74% |
| 2016-12-31 | CN¥265.49 Million ≈ $38.85 Million |
CN¥55.00 Million ≈ $8.05 Million |
0.207x | -35.02% |
| 2015-12-31 | CN¥151.66 Million ≈ $22.19 Million |
CN¥48.35 Million ≈ $7.07 Million |
0.319x | +0.43% |
| 2014-12-31 | CN¥88.06 Million ≈ $12.89 Million |
CN¥27.95 Million ≈ $4.09 Million |
0.317x | -- |
About Imeik Technology Development Co
Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate compos… Read more